Drug Licensing & Collaboration
Milestones, royalties, field-of-use, diligence, regulatory progress, termination and IP rights.
LicenceMilestoneRoyalty
Sector Bench · Life Sciences, Pharmaceuticals & Healthcare
In life sciences, the contract sits beside science, regulation, patient risk and intellectual property.
Licensing, clinical research, manufacturing, distribution, biosimilars, digital health and regulatory milestones create disputes where technical and legal issues cannot be separated. UNIONE™ brings sector intelligence to prevention, evaluation, arbitration readiness and enforcement.
LicensingClinical TrialsCROGxPSupplyBiosimilarsPatentsDigital Health
Transactions / Corporate
In life sciences, the contract sits beside science, regulation, patient risk and intellectual property.
Disputes are sectoral before they are procedural.Before You Sign™. Before You Arbitrate™. Before You Enforce™.Use the smallest credible intervention before escalating to the largest one.A life-sciences dispute can be created by a scientific milestone that the contSector credibility should be visible in the frameworks practitioners actually The full dispute ecosystem.Sector standing should mean genuine capability - not automatic work.Submit from anywhere. Coordinate centrally. Use local counsel where domestic l
Deep reference
Jump directly into this page.
Tip. Use Ask UNIONE for a page-aware route suggestion. Production AI connects through a protected server endpoint; API keys never sit in browser code.
SectionDisputes are sectoral before they are procedural.SectionBefore You Sign™. Before You Arbitrate™. Before You Enforce™.SectionUse the smallest credible intervention before escalating to the largest one.SectionA life-sciences dispute can be created by a scientific milestone that the contSectionSector credibility should be visible in the frameworks practitioners actually SectionThe full dispute ecosystem.SectionSector standing should mean genuine capability - not automatic work.SectionSubmit from anywhere. Coordinate centrally. Use local counsel where domestic lSectionThe Bench should live between appointments.SectionWhat is happening right now?SectionA fuller decision view.SectionThis issue does not live alone.SectionThe dispute should not be the first time anyone studies the dispute architectu
✚ Sector Bench · UNIONE™
Life Sciences, Pharma & Healthcare
Life Sciences, Pharma & Healthcare disputes become easier to understand when the operating event, contract architecture, evidence, specialist context and recovery route are kept connected from the start.
LicensingSupplyClinicalIPRegulatoryQualityPricingDistribution
Operating eventStart with factsIdentify what changed commercially or technically.
Contract mechanismMap the triggerConnect the event to notices, rights, remedies and escalation.
EvidencePreserve the recordStructure documents, data and specialist proof early.
RecoveryLook downstreamKeep assets, security and jurisdiction visible before the final decision.
Before You Sign™Contract Intelligence™
Review the dispute architecture before risk is locked into the deal.
Open route →Before You Arbitrate™Independent Assessment™
Test evidence, exposure and alternatives before formal process.
Open route →ArbitrationApplicable procedure
Use sector-informed expertise under the applicable agreement and operative rules.
Open route →Before You Enforce™Enforcement intelligence
Connect the right to debtor, assets, security and jurisdiction.
Open route →01EventOperating fact
02MechanismContract / regulation
03EvidenceRecord / expert
04DecisionResolve · arbitrate · recover
Current-status control. Sector use cases are preserved and made easier to navigate without reviving legacy fixed fees, unsupported market statistics, automatic later appointments, universal ERR™, or draft Rules as operative procedure.
Page intelligence · Transactions / Corporate
Use this page to decide how deal allocation, control, post-closing event and exit / recovery interact.
This layer turns the page into a working decision map. Read the substantive analysis below, use the lenses to frame the issue, move sideways into connected UNIONE™ services, or ask the page-aware assistant to suggest a route through the institution.
Decision lens 01Deal allocation
Representations, warranties, indemnities, disclosure and price mechanics.
Decision lens 02Control
Shareholder rights, JV governance, reserved matters and deadlock.
Decision lens 03Post-closing event
Earn-out, completion accounts, leakage and covenant issues.
Decision lens 04Exit / recovery
Remedies, security, valuation and enforcement.
Use this withConnected current canonicals
Ask UNIONE about this pagePage-aware prompts
Go directlyDisputes are sectoral before they are procedural.Before You Sign™. Before You Arbitrate™. Before You Enforce™.Use the smallest credible intervention before escalating to the largest oneA life-sciences dispute can be created by a scientific milestone that the cSector credibility should be visible in the frameworks practitioners actualThe full dispute ecosystem.Sector standing should mean genuine capability - not automatic work.Submit from anywhere. Coordinate centrally. Use local counsel where domesti
01 · Sector reality
Disputes are sectoral before they are procedural.
The page begins with the disputes, documents and commercial decisions that practitioners in this field actually face.
Clinical Trial / CRO Disputes
Protocol, recruitment, data quality, site management, delay, safety reporting and payment.
CROTrialData
Pharmaceutical Supply
Quality, batch failure, shortages, recalls, cold chain, forecasting and take-or-pay obligations.
GMPSupplyRecall
Patent / Biosimilar Licensing
Patent scope, freedom-to-operate, royalty, exclusivity, biosimilar entry and settlement terms.
PatentBiosimilarRoyalty
Regulatory Milestone Disputes
Approval responsibility, submission timing, change control, pharmacovigilance and regulatory delay.
ApprovalPVMilestone
Digital Health & Health Tech
Software performance, data, medical-device interfaces, AI use, interoperability and clinical responsibility.
Digital healthDataAI
02 · Three buying moments
Before You Sign™. Before You Arbitrate™. Before You Enforce™.
Start with the decision the organisation faces - not the name of an institutional product.
Before You Sign™
Stress-test dispute-facing architecture while it can still be changed.
- Definitions, triggers and evidence
- Governance / escalation architecture
- Governing law, seat and enforcement destinations
- DPC™ / Standing Neutral design where appropriate
- Sector-specific risk allocation
Before You Arbitrate™
Separate legal entitlement from the commercial decision before full proceedings consume time and capital.
- Claim / counterclaim framing
- Evidence and quantum review
- Sector-specialist neutral evaluation
- Expert determination where agreed
- Arbitration readiness and procedure
Before You Enforce™
Think about recognition, assets and execution before enforcement becomes urgent.
- Target-jurisdiction intelligence
- Asset and recognition pathway
- State / SOE issues where relevant
- Enforceability Opinion™ for relevant awards
- ERR™ where the applicable institutional process provides for it
03 · Prevention → resolution
Use the smallest credible intervention before escalating to the largest one.
UNIONE™ should offer a progression - not treat arbitration as the only answer.
01
Pre-contract / DPC™
Stress-test IP, regulatory milestones, quality, supply, data, safety reporting, evidence and dispute architecture before collaboration begins.
02
Neutral evaluation
Use sector-informed assessment for milestone, licensing, quality, clinical, regulatory, supply or performance disagreements before escalation.
03
Expert determination
Where agreed, route scientific, accounting, milestone, quality, valuation or technical questions to a suitably qualified expert.
04
Arbitration
Where binding adjudication is necessary, protect confidential science and patient-sensitive material while matching tribunal and expert capability to the dispute.
04 · Sector-specific prevention
A life-sciences dispute can be created by a scientific milestone that the contract never defined precisely.
The prevention layer should make regulatory events, trial data, quality obligations, IP ownership, milestone economics and evidence requirements contractually usable before they become contested facts.
Contract review
Six checkpoints. Sector-specific emphasis.
DPC™ is an institutional prevention framework. It can surface dispute-facing weaknesses and structure escalation, but it does not guarantee that a dispute will be avoided or that any particular outcome will follow.
01
Milestone precision
Define scientific, clinical, regulatory and commercial milestones with objective triggers, evidence and responsibility.
02
IP & data rights
Allocate background / foreground IP, trial data, know-how, publication, use rights and post-termination access.
03
Quality & supply
Clarify GMP / quality responsibilities, forecasting, batch release, shortage, recall, audit and remediation obligations.
04
Regulatory responsibilities
Map submissions, approvals, safety reporting, pharmacovigilance, change control and regulator-facing duties.
05
Confidentiality & sensitive evidence
Protect trade secrets, clinical data, personal data, patient-sensitive material and scientific records.
06
Escalation architecture
Separate operational cure, scientific / technical determination, executive escalation, neutral evaluation and arbitration.
05 · Contract & practice frameworks
Sector credibility should be visible in the frameworks practitioners actually use.
Bench standing is stronger when capability can be traced to real contracts, evidence, regulation or commercial mechanics.
Pharma / biotech licence agreementsIP · milestones · royalties · diligence · regulatory progress
Clinical Trial / CRO AgreementsProtocol · recruitment · data · quality · safety · payment
Manufacturing / Supply AgreementsGMP · batch release · forecasting · recall · shortage
Distribution & CommercialisationTerritory · promotion · compliance · supply · pricing
Patent / Biosimilar ArrangementsLicence scope · settlement · royalty · entry · exclusivity
Digital Health / MedTech ContractsSoftware · device · data · AI · interoperability · responsibility
06 · Who this serves
The full dispute ecosystem.
Different users arrive with different decisions. Each should be able to see where UNIONE™ may become relevant without being forced into arbitration-first language.
Pharma & biotech companies
Licensing, development, milestones, supply, regulatory and commercialisation disputes.
Clinical sponsors & CROs
Protocol, recruitment, data, quality, delay, safety reporting and payment disputes.
Manufacturers & CDMOs
Quality, technology transfer, capacity, batch failure, supply and recall exposure.
Healthcare / MedTech businesses
Devices, digital health, software, data, AI and clinical-responsibility disputes.
Investors & strategic partners
Milestone economics, IP, regulatory progress, valuation and collaboration risk.
Insurers & funders
Product / transaction exposure, valuation, recovery prospects and dispute-readiness questions.
07 · Sector Bench
Sector standing should mean genuine capability - not automatic work.
UNIONE™ Fellowship and Sector Bench standing create an institutional credential and eligibility environment. They do not create entitlement to appointments, cases, referrals, paid work or any particular commercial outcome.
Q
Qualification
Relevant legal, medical, pharmaceutical, scientific, regulatory, engineering, accounting or other professional qualification.
E
Experience
Meaningful pharmaceutical, biotech, healthcare, clinical, medtech, regulatory, licensing, supply or dispute experience.
S
Sector knowledge
Demonstrable familiarity with life-sciences contracting, scientific / regulatory evidence, IP, quality or healthcare-sector practice.
S
Specialism
A defined life-sciences, pharma, healthcare, clinical, regulatory or related specialism rather than generic dispute experience.
I
Independence
Ability to satisfy conflict, independence and impartiality requirements for any role for which the person is considered.
Appointment firewall
Any arbitral, neutral, expert or other appointment is separately determined by the applicable procedure, the needs of the matter, independence and conflict checks, party choice where relevant, and institutional suitability. Sector Bench standing does not guarantee appointment and does not predetermine a Fellow’s role in any later dispute.
08 · Global by design
Submit from anywhere. Coordinate centrally. Use local counsel where domestic law requires it.
UNIONE™ is designed for cross-border delivery without pretending that every jurisdictional function can be performed remotely by the institution itself.
Remote institutional delivery
The institutional layer can travel.
Digital submission, secure document exchange, video meetings, central coordination, sector-specialist review and jurisdiction-specific intelligence can operate across borders.
The professional boundary
Reserved domestic-law work stays with appropriately qualified local counsel.
Where actual domestic-law advice, court representation, regulated legal activity or another locally reserved function is required, the client should obtain appropriately qualified local counsel. UNIONE™ may identify the need or coordinate relevant input where appropriate without blurring that boundary.
09 · Year-round relevance
The Bench should live between appointments.
Fellowship becomes more credible when it connects to year-round professional relevance, knowledge and institutional participation - not a promise that UNIONE™ will distribute cases.
Global Business Circuit™
Sector expertise can enter real cross-border conversations.
Relevant Fellows may contribute to sector, jurisdiction and Business Corridor programmes where their expertise fits the subject. The Circuit is a relevance and participation environment, not a lead-distribution or referral guarantee.
Institutional chronology
Barcelona → Circuit → Paris.
Aug 2026Barcelona Assembly completed. It is now institutional history and record, not an upcoming induction promise.
2026-27Year-round Global Business Circuit™, sector work, institutional programmes and Fellowship activity.
May 2027The Paris Assembly™ - the next annual global convergence for the wider UNBOUNDED™ ecosystem and participating institutions.
10 · Decision router
What is happening right now?
Start with the live business problem. The institutional pathway comes second.
Choose one
Bring the current decision.
This router does not determine legal rights. It helps a visitor reach the most relevant UNIONE™ starting point.
Choose the situation above.
UNIONE™ will point the visitor to the most relevant first door.
Deeper intelligence
A fuller decision view.
This page combines the current 2027 institutional architecture with the deeper commercial and dispute analysis developed in the comprehensive Solutions build.
Scientific evidence must remain evidence-not advocacy dressed as science.
A specialist tribunal can understand the context, but disputed technical facts still require reliable expert and documentary proof.
How was it generated, validated, stored and analysed?
Clinical design - What was required, changed and approved?
Trial / quality data - How was it generated, validated, stored and analysed?
Private procedure must coexist with mandatory regulation.
UNIONE™'s value is not in replacing regulators. It is in structuring the commercial relationship, evidence and specialist adjudication around the regulated environment.
The arbitration clause is activated after milestone, supply, IP or distribution failure.
Contract Intelligence™ identifies regulatory and technical dependencies before they generate claims.
Technical questions can be isolated before the whole relationship fails.
Expert determination, neutral evaluation and arbitration can play different roles.
Technical performance, milestone, accounting or defined scientific questions where contractually suitable.
Test liability and evidential exposure before full proceedings.
Preserve collaboration / supply where the commercial relationship still has value.
Current-status control. Earlier material has been retained only where it adds substantive decision value. Legacy claims on Rules effectiveness, universal ERR™, automatic appointments, fixed timings, unstable counts and historical Barcelona-forward language are not carried into this page.
UNIONE™ · connected intelligence
In life sciences, the contract sits beside science, regulation, patient risk and intellectual property.
UNIONE™ Fellows · relevant here
Meet the professionals connected to this subject.
Fellows are surfaced by jurisdiction, sector, industry and relevant dispute experience so the professional community is visible throughout the UNIONE™ universe. Directory visibility supports discovery only. Any appointment is separately determined by the applicable procedure, independence, conflicts, suitability and party choice where relevant.
Real Estate and Property DisputesTransactions / Corporate
UNIONE™ Universe · Connected decisions
This issue does not live alone.
Move sideways into the relevant intelligence, upstream into contract and prevention, or downstream into assessment, arbitration and enforcement. This is how the wider UNIONE™ system connects around the decision.
Specialist sector
Sector Benches
Add the specialist operating and regulatory layer before choosing the forum.
Open connected route →
Specialist sector
Aviation, Aerospace & Airports Disputes™
Add the specialist operating and regulatory layer before choosing the forum.
Open connected route →
Specialist sector
Real Estate & Property Disputes™
Add the specialist operating and regulatory layer before choosing the forum.
Open connected route →
Construction & projects
Telecom
Connect project event, contemporaneous record, causation and valuation.
Open connected route →
Contract & prevention
Distribution Agreements™
Connect the issue to contract architecture, clause design and prevention before escalation.
Open connected route →
Contract & prevention
Licensing & IP Agreements™
Connect the issue to contract architecture, clause design and prevention before escalation.
Open connected route →
Transactions & corporate
Transaction Intelligence™
Connect deal allocation, control, post-closing events and exit / recovery.
Open connected route →
Contract & prevention
Before You Sign™
Connect the issue to contract architecture, clause design and prevention before escalation.
Open connected route →
UNIONE™ service layer · relevant here
Life Sciences, Pharmaceuticals & Healthcare · UNIONE™
The dispute should not be the first time anyone studies the dispute architecture.
Bring a contract, a live dispute decision, an enforcement question - or your professional capability.